Thrivent Financial for Lutherans
EVH icon

Thrivent Financial for Lutherans’s Evolent Health EVH Stock Holding History

Thrivent Financial for Lutherans’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-56,736
Closed -$1.84M – 2482
2023
Q1 		$1.84M Buy
+56,736
New +$1.79M ﹤0.01% 1350
2019
Q1 		– Sell
-198,933
Closed -$3.97M – 2154
2018
Q4 		$3.97M Buy
198,933
+751
+0.4% +$17.4K 0.01% 665
2018
Q3 		$5.63M Sell
198,182
-23,859
-11% -$569K 0.02% 630
2018
Q2 		$4.67M Buy
222,041
+1,203
+0.5% +$22.8K 0.02% 668
2018
Q1 		$3.15M Sell
220,838
-78,012
-26% -$1.12M 0.01% 758
2017
Q4 		$3.68M Sell
298,850
-171,830
-37% -$2.42M 0.01% 726
2017
Q3 		$8.38M Buy
470,680
+223,230
+90% +$4.6M 0.03% 483
2017
Q2 		$6.27M Buy
+247,450
New +$5.95M 0.03% 511

Other funds holding EVH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Thrivent Financial for Lutherans's EVH Position: Q2 2023 in Review

Thrivent Financial for Lutherans sold out of Evolent Health (EVH) in Q2 2023, closing a stake of 56,736 shares — an estimated $1.84M sold.

Thrivent Financial for Lutherans first reported a position in EVH in Q2 2017 and held it in 8 quarters. The position peaked at $8.38M in Q3 2017. 217 funds tracked by Wall St. Rank hold EVH as of Q2 2023.

  • Thrivent Financial for Lutherans reported no remaining Evolent Health position as of Q2 2023 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 56,736 Evolent Health shares in Q2 2023, an estimated $1.84M.
  • Thrivent Financial for Lutherans first reported a position in Evolent Health in Q2 2017 and held it in 8 quarters.
  • Thrivent Financial for Lutherans's Evolent Health position peaked at $8.38M in Q3 2017.
  • 217 funds tracked by Wall St. Rank held Evolent Health as of Q2 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2023, filed 14 Aug 2023.